<DOC>
	<DOCNO>NCT02275585</DOCNO>
	<brief_summary>This study evaluate supervivence cirrhotic patient develop portal vein thrombosis comparison cirrhotic patient develop portal vein thrombosis .</brief_summary>
	<brief_title>Portal Vein Thrombosis Cirrhosis</brief_title>
	<detailed_description>Patients newly diagnose portal vein thrombosis imaging test , evaluate extent exclude tumoral origin , include ( informed consent previously sign ) . Anticoagulant treatment initiate accord clinical guideline ( contraindication ) first LMWH ( low molecular weight heparin ) later dicoumarin . An abdominal CT perform evaluate extent exclude tumoral origin ; gastroscopy evaluate portal hypertension ( prophylaxis require ) thrombophilia study . Patients follow imaging laboratory test every 6 month ; evaluate response treatment detect cirrhosis complication .</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Budd-Chiari Syndrome</mesh_term>
	<criteria>Cirrhosis diagnose liver biopsy noninvasive methods/clinical , analytics ultrasound usual criterion Portal vein thrombosis newly diagnose ( define partial complete obstruction splenoportal vessel objectify image with/without symptomatology ) â‰¤ 6 month . Over 18 year old Want participate ( informed consent ) Pregnant lactate Patients tumoral vein thrombosis elevate alphafetoprotein high suspicion underlie neoplastic disease . Thrombocytopenia &lt; 25.000 . Patients cavernomatosis portal vein thrombosis already know . Patient refusal participate Patients already treat anticoagulant disease ( atrial fibrillation , pulmonary thrombosis ... )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Portal vein</keyword>
	<keyword>Thrombosis</keyword>
	<keyword>Cirrhosis</keyword>
</DOC>